13F Holdings
中文EN

MHUAF Meihua International Medical Technologies Co., Ltd. Annual reports only

Surgical & Medical Instruments & Apparatus · OTC · SEC CIK 1835615 · Fiscal year ends 12/31

Financial factors as of 2025-12-31 (FY2025), by fiscal year; growth vs the previous fiscal year

Growth

TTM revenue YoY-36.2%
TTM net income YoY-37.5%
TTM EPS YoY-54.5%
Revenue 3-yr CAGR-15.8%
Net income 3-yr CAGR2.8%

Margins

Gross margin31.0%
Operating margin13.4%
Net margin11.0%
FCF margin0.9%
EBITDA margin14.3%

Returns

ROE3.9%
ROA3.4%
ROIC (approx.)3.8%
Asset turnover0.31x

Leverage & solvency

Liabilities / assets8.8%
Debt / equity0.00x
Current ratio8.42x
Interest coverage34.30x

Cash quality & payout

Operating cash flow / net income0.08x
Accruals ratio3.2%
Payout ratio—
Capex / revenue0.0%

Factor history charts and full statement history on Pro 🔒

Financial statements

Annual Quarterly (none) Export CSV 🔒
Line item FY20252025-12-31FY20242024-12-31FY20232023-12-31FY20222022-12-31FY20212021-12-31
Income statement
Revenue$61.79M$96.91M$97.10M$103.35M$104.04M
Cost of revenue$42.63M$63.61M$63.90M$65.25M$64.23M
Gross profit$19.16M$33.30M$33.20M$38.10M$39.81M
R&D expense$2.38M$3.46M$2.75M$2.96M$2.73M
SG&A expense$3.21M$7.78M$6.54M$12.47M$4.36M
Operating income$8.28M$14.31M$14.67M$10.80M$26.26M
Interest expense$241,523$1.51M$250,781$191,198$180,744
Pretax income$9.41M$13.63M$15.05M$10.89M$26.23M
Income tax$2.62M$2.79M$3.46M$4.71M$5.28M
Net income$6.78M$10.84M$11.63M$6.24M$20.95M
EBITDA$8.82M$14.86M$15.08M$11.34M$26.86M
EPS (basic)18.0439.6248.560.271.05
EPS (diluted)18.0439.6248.560.271.05
Weighted avg. shares (diluted)376,035273,717239,40023.41M20.00M
Banking
Net interest income—-$1.51M-$250,781-$194,667-$180,744
Deposits———$7.00M—
Balance sheet
Cash & equivalents$15.15M$17.29M$16.93M$26.74M$8.15M
Receivables$84.33M$78.66M$78.57M$68.95M$67.10M
Inventory$1.70M$1.41M$1.62M$1.12M$1.25M
Current assets$153.58M$143.44M$132.24M$135.32M$97.28M
PP&E, net$7.70M$7.89M$8.83M$8.76M$7.48M
Goodwill—$7.90M———
Intangibles$446,495$443,035$3.92M$497,600$562,001
Total assets$207.18M$186.24M$171.92M$163.58M$136.86M
Current liabilities$18.25M$27.26M$25.07M$24.17M$29.09M
Short-term debt$8.99M$7.95M$7.32M$6.09M$5.18M
Long-term debt———$724,932—
Total debt———$6.81M—
Total liabilities$18.25M$27.26M$25.08M$24.90M$29.09M
Shareholders' equity$188.93M$158.98M$146.33M$138.12M$107.77M
Net debt———-$19.92M—
Shares outstanding—31.90M23.94M20.00M20.00M
Cash flow statement
Operating cash flow$569,883$14.64M$2.28M-$9.16M-$54,663
Capital expenditure$15,629$133,550$1.18M$2.70M$850,231
Free cash flow$554,254$14.50M$1.09M-$11.86M-$904,894
Investing cash flow-$20.13M-$20.42M-$12.46M-$8.62M-$833,817
Financing cash flow$17.19M$6.21M$706,125$37.25M$1.86M
Depreciation & amortization$533,963$543,658$408,233$541,265$595,522
Share buybacks—$200,000———

Free plan shows the latest 5 periods; Pro shows all 7 🔒

· This company files only annual reports with the SEC (20-F for foreign issuers), so there is no quarterly data; factors are by fiscal year and growth is vs the previous fiscal year.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.